ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2010, Vol. 19 ›› Issue (5): 430-434.

• 论文 • 上一篇    下一篇

腹腔镜下腹膜透析置管术的疗效及安全性

  

  • 出版日期:2010-10-28 发布日期:2010-11-05

Efficacy and safety of laparoscopic and conventional placement of peritoneal dialysis catheters in patients with ESRD

  • Online:2010-10-28 Published:2010-11-05

摘要:

目的:本研究是为了比较腹腔镜与常规腹透置管术的疗效和安全性。方法:前瞻性随机入选我科自200812月到20104月首次置管并接受PD治疗的ESRD患者共50例,随机分为腹腔镜组(A组)和常规手术组(B组)各25例,记录术前两组的基本情况、并发症、生存时间、退出或死亡等结局;同时对腹腔镜组患者比较术前、术后肝肾功能。结果:截止20106月。5(10%)死亡,其中A2例、B3例,两组10个月生存率分别为(A组)86.6vsB组)82.9%(P>0.05)。两组总共发生腹膜炎9(12例次),总腹膜炎发生率为0.29次/病人年, A组腹膜炎发生率(0.24/病人年)低于B组(0.34/病人年)(P>005)。两组首次腹膜炎发生率分别为A组(31.7923.8)周,B组(14.9310.40)周(P>0.05) 2皮下隧道及出口感染均发生于A(P>005)。各项机械并发症差异均无统计学意义(P>005),但A组无漂管发生,B组中却发生4(P=0.055)。腹腔镜组术前术后肝肾功能无差异。结论:腹腔镜下腹透置管可以降低术后近期内腹透感染率;从根本上解决腹透漂管,而且腹腔镜组患者术后未出现肝肾功能损害。

Abstract:

Objective: To compare the efficacy and safety between laparoscopic and  conventional placement of peritoneal dialysis (PD) catheters prospectively in patients with end-stage renal disease (ESRD)Methodology: Fifty patients with ESRD were selected as candidates, who received catheter implantation and CAPD therapy from December 2008 to April 2010 for the first timeThey were randomly divided into group A (with laparoscopic placement of PD catheter, n=25) and group B (with conventional placement of PD catheter, n=25). The clinical information such as complications, survival time, quit of dialysis, death, etc was collected. At same time, the liver and renal functions between preoperative and postoperative stage were compared between two groups. Results: Till to June 2010, 5 patients (10%) died, including 2 in group A and 3 cases in group B. The survival rate of 10 months was 86.6% (group A) and 82.9% (group B), respectively (P> 0.05). The total incidence of peritonitis was 0.29 times/patient year, with a detailed figure of 0.24 for group A and 0.34 times/patient year for group B respectively (P>0.05)The time interval between catheter implanting and onset of peritonitis was 31.8±23.8 and 14.9±10.4 weeks for group A and group B respectively (P>0.05). There was no catheter migration in group A, while 4 cases in group B (P>0.05).The other complications of catheter between two groups were not significantly different (P>0.05). In group A, the liver and kidney functions of before and after surgery were no significant difference. Conclusions: The incidence of peritonitis shortly after operation in group A was slightly decreased. More importantly, it can solve the problem of catheter migration through laparoscopic placement. Meanwhile, the general anesthesia and artificial pneumoperitoneum did not affact the liver and renal functions of patients with ESRD.